TIL · Instil Bio, Inc.
AI read · Neutral
The AI's read
Lower spending helped narrow the loss, but it does not show stronger development progress: research and development spending was only $0.2 million for the quarter. Cash also fell from $76.3 million at year-end 2025 to $67.1 million, though the company expects enough to fund its plan through 2027.